Advances in the development of gene therapy, noncoding RNA, and exosome-based treatments for tendinopathy

Area of Science:

• Musculoskeletal disorders
• Tissue regeneration
• Cellular biology

Background:

• Tendinopathy is a prevalent musculoskeletal condition marked by chronic inflammation and tendon degeneration.
• Tendons possess limited natural healing capacity, and current treatments are insufficient.
• Understanding tendinopathy pathogenesis and tendon development offers new therapeutic targets.

Purpose of the Study:

• To review current knowledge and treatments for tendinopathy.
• To highlight emerging therapeutic strategies for tendon repair.
• To explore the potential of gene therapy, noncoding RNAs, and exosomes in treating tendinopathy.

Main Methods:

• Literature review of studies on tendinopathy pathogenesis and development.
• Analysis of current treatment modalities for tendinopathy.
• Evaluation of recent advances in regenerative medicine for tendon healing.

Main Results:

• Current understanding of tendinopathy pathogenesis has identified novel therapeutic targets.
• Gene therapy, microRNAs, and exosomes represent promising avenues for enhanced tendon healing.
• Regenerative approaches offer potential for improved outcomes in tendinopathy treatment.

Conclusions:

• Despite challenges, advances in understanding tendinopathy are paving the way for innovative treatments.
• Gene therapy, noncoding RNAs, and exosomes hold significant potential for future tendinopathy therapies.
• Further research into these novel strategies is crucial for developing effective cures for tendinopathy.